Skip to search formSkip to main contentSkip to account menu

CI 921

Known as: CI-921 
A synthetic derivative of acridine carboxamide with antineoplastic properties. CI-921, a lipophilic and water-soluble analog of amsacrine, inhibits… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Purpose: Amsalog, a derivative of 9-aminoacridine, is an inhibitor of topoisomerase II. Early studies of intravenous amsalog… 
2004
2004
CI-921, (9-[[2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino]-N,5-dimethyl-4-acridinecarboxamide 2-hydroxyethanesulfonate (1∶1… 
2004
2004
SummaryN-5-dimethyl-9-[(2-methoxy-4-methylsulphonylamino)phenylamino]-4-acridinecarboxamide (CI-921), which is an analogue of… 
2001
2001
Abstract.Purpose: Amsalog is a derivative of 9-aminoacridine. Phase I studies using intravenous (i.v.) amsalog have shown the… 
1990
1990
The aim was to investigate interspecies relationships between body weight (W) (kg) and various pharmacokinetic parameters for the… 
1990
1990
9-([2-Methoxy-4-[(methylsulfonyl)amino]phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921), an analogue of the clinical… 
1988
1988
CI-921, an analogue of amsacrine with superior activity against in vivo and in vitro experimental tumor models, has been studied… 
1988
1988
The antitumour agent 9-[[2-methoxy-4-[methylsulphonylamino]-phenyl]amino]-N,5-dimethyl- 4-acridinecarboxamide (CI-921; NSC 343499… 
1986
1986
  • P. Frank, R. Novak
  • Biochemical and biophysical research…
  • 1986
  • Corpus ID: 32460791